Results 1 to 10 of about 83,725,006 (209)

Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor

open access: yesJournal of Pharmacological Sciences, 2006
Mutations producing constitutively active G-protein coupled receptors have been found in the pathophysiology of several diseases, implying that inverse agonists at the constitutively active receptors may have preferred therapeutic applications.
Habib Abul Muntasir   +4 more
doaj   +9 more sources

Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential [PDF]

open access: yesNature Communications, 2023
Serotonergic psychedelics possess considerable therapeutic potential. Although 5-HT2A receptor activation mediates psychedelic effects, prototypical psychedelics activate both 5-HT2A-Gq/11 and β-arrestin2 transducers, making their respective roles ...
Jason Wallach   +18 more
doaj   +3 more sources

A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear [PDF]

open access: yesInternational Journal of Neuropsychopharmacology, 2021
Background: Though drugs binding to serotonergic 5-HT2A receptors have long been claimed to influence human anxiety, it remains unclear if this receptor subtype is best described as anxiety promoting or anxiety dampening.
Elias Eriksson   +2 more
exaly   +3 more sources

5-HT2A receptor activation induces CB1-dependent presynaptic inhibitory long-term depression in the nucleus accumbens core [PDF]

open access: yesFrontiers in Pharmacology
The serotonin 2A receptor (5-HT2A) is a Gq/11-coupled receptor implicated in reward processing, neuropsychiatric disorders, and the actions of serotonergic psychedelics.
Camila Estay-Olmos   +12 more
doaj   +2 more sources

Biased signaling via serotonin 5-HT2A receptor: From structural aspects to in vitro and in vivo pharmacology [PDF]

open access: yesActa Pharmaceutica Sinica B
G protein-coupled receptors (GPCRs) represent key drug targets, with approximately 30%–40% of all medications acting on these receptors. Recent advancements have uncovered the complexity of GPCR signaling, including biased signaling, which allows ...
Michał K. Jastrzębski   +11 more
doaj   +2 more sources

PACAP–PAC1 Signaling Regulates Serotonin 2A Receptor Internalization

open access: yesFrontiers in Endocrinology, 2021
Mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) display psychomotor abnormalities, most of which are ameliorated by atypical antipsychotics with serotonin (5-HT) 2A receptor (5-HT2A) antagonism. Heterozygous Pacap mutant mice show
Atsuko Hayata-Takano   +12 more
doaj   +1 more source

Serotonin 5-HT2A receptor activity mediates adipocyte differentiation through control of adipogenic gene expression

open access: yesScientific Reports, 2021
Serotonin 5-HT2 receptors are expressed in many tissues and play important roles in biological processes. Although the 5-HT2A receptor is primarily known for its role in central nervous system, it is also expressed in peripheral tissues.
Bangning Yu   +3 more
doaj   +1 more source

St. John's wort extract STW3-VI affects the binding behaviour, signal transduction and lateral mobility of 5-HT2A receptors observed by single molecule detection and the use of a novel fluorescence-labeled ligand

open access: yesPhytomedicine Plus, 2022
Background: 5-HT2A receptors play an important role in the development and therapy of depression. St. John's wort (SJW) extracts are used in the treatment of depression.
Stefan Aatz   +3 more
doaj   +1 more source

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

open access: yesFrontiers in Neuroergonomics, 2022
Psilocybin (a serotonin 2A, or 5-HT2A, receptor agonist) has shown preliminary efficacy as a treatment for mood and substance use disorders. The current report utilized positron emission tomography (PET) with the selective 5-HT2A receptor inverse agonist
Frederick S. Barrett   +9 more
doaj   +1 more source

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines

open access: yesFrontiers in Pharmacology, 2022
3,4,5-Trimethoxyphenethylamine (mescaline) is a psychedelic alkaloid found in peyote cactus. Related 4-alkoxy-3,5-dimethoxy-substituted phenethylamines (scalines) and amphetamines (3C-scalines) are reported to induce similarly potent psychedelic effects ...
Karolina E. Kolaczynska   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy